| Dr Tuyen T Trinh, D.o.,pllc | |
|
118 Baxter St Room 502 New York NY 10013-3602 | |
| (212) 233-6662 | |
| (212) 233-6663 |
| Full Name | Dr Tuyen T Trinh, D.o.,pllc |
|---|---|
| Speciality | Family Medicine |
| Location | 118 Baxter St, New York, New York |
| Authorized Official Name and Position | Tuyen T Trinh (PRESIDENT) |
| Authorized Official Contact | 2122336662 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tuyen T Trinh, D.o.,pllc 118 Baxter St Room 502 New York NY 10013-3602 Ph: (212) 233-6662 | Dr Tuyen T Trinh, D.o.,pllc 118 Baxter St Room 502 New York NY 10013-3602 Ph: (212) 233-6662 |
| NPI Number | 1003029232 |
|---|---|
| Provider Enumeration Date | 05/07/2007 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 2466476700 |
|---|---|
| Medicare Enrollment ID | O20060125000473 |
News Archive
Researchers at Massachusetts Eye and Ear/Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. This discovery, published July 30 in Cell Reports, could potentially be used to design gene therapies that are not only safer and more potent than therapies currently available, but may also help a greater number of patients.
According to researchers, screening for the AIDS virus to include every American at least once and the highest-risk people once a year could prevent more than 80,000 infections over the next 20 years. The team from Yale University in Connecticut and Stanford University in California reported that if treatment for infected people were integrated into such a program, it would prevent an estimated 212,000 new infections.
Recognized for their pioneering work in the development of gene transfer technology using retroviral vectors to deliver therapeutic genes into cells, Richard C. Mulligan, PhD, Director of the Harvard Gene Therapy Initiative, Harvard Institutes of Medicine, Boston, MA, and A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Just as the risk of developing alcoholism is strongly influenced by genetic factors, mutations in gene coding - such as the aldehyde dehydrogenase (ALDH2*2) allele - also appear to protect against the risk.
Trials of a screen-based malaria prevention programme in 500 homes in The Gambia, Africa, have led to a 50 per cent reduction in malaria transmission and anaemia in children. A child dies from malaria in Africa every 30 seconds and infection can lead to an increased risk of anaemia, which can also prove fatal. Yet to date, screens have often been ignored in favour of using drugs and insecticides.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003029232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 204862 (New York) | Primary |
| Provider Name | Tuyen T Trinh |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1780682203 PECOS PAC ID: 4789603853 Enrollment ID: I20051117000558 |
News Archive
Researchers at Massachusetts Eye and Ear/Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. This discovery, published July 30 in Cell Reports, could potentially be used to design gene therapies that are not only safer and more potent than therapies currently available, but may also help a greater number of patients.
According to researchers, screening for the AIDS virus to include every American at least once and the highest-risk people once a year could prevent more than 80,000 infections over the next 20 years. The team from Yale University in Connecticut and Stanford University in California reported that if treatment for infected people were integrated into such a program, it would prevent an estimated 212,000 new infections.
Recognized for their pioneering work in the development of gene transfer technology using retroviral vectors to deliver therapeutic genes into cells, Richard C. Mulligan, PhD, Director of the Harvard Gene Therapy Initiative, Harvard Institutes of Medicine, Boston, MA, and A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Just as the risk of developing alcoholism is strongly influenced by genetic factors, mutations in gene coding - such as the aldehyde dehydrogenase (ALDH2*2) allele - also appear to protect against the risk.
Trials of a screen-based malaria prevention programme in 500 homes in The Gambia, Africa, have led to a 50 per cent reduction in malaria transmission and anaemia in children. A child dies from malaria in Africa every 30 seconds and infection can lead to an increased risk of anaemia, which can also prove fatal. Yet to date, screens have often been ignored in favour of using drugs and insecticides.
› Verified 5 days ago
News Archive
Researchers at Massachusetts Eye and Ear/Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. This discovery, published July 30 in Cell Reports, could potentially be used to design gene therapies that are not only safer and more potent than therapies currently available, but may also help a greater number of patients.
According to researchers, screening for the AIDS virus to include every American at least once and the highest-risk people once a year could prevent more than 80,000 infections over the next 20 years. The team from Yale University in Connecticut and Stanford University in California reported that if treatment for infected people were integrated into such a program, it would prevent an estimated 212,000 new infections.
Recognized for their pioneering work in the development of gene transfer technology using retroviral vectors to deliver therapeutic genes into cells, Richard C. Mulligan, PhD, Director of the Harvard Gene Therapy Initiative, Harvard Institutes of Medicine, Boston, MA, and A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Just as the risk of developing alcoholism is strongly influenced by genetic factors, mutations in gene coding - such as the aldehyde dehydrogenase (ALDH2*2) allele - also appear to protect against the risk.
Trials of a screen-based malaria prevention programme in 500 homes in The Gambia, Africa, have led to a 50 per cent reduction in malaria transmission and anaemia in children. A child dies from malaria in Africa every 30 seconds and infection can lead to an increased risk of anaemia, which can also prove fatal. Yet to date, screens have often been ignored in favour of using drugs and insecticides.
› Verified 5 days ago
Debra Green, Md Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 115 E 57th St, Suite 510, New York, NY 10022 Phone: 212-584-5402 Fax: 212-744-4072 | |
S. Nadesan Physician, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 308a East 15th Street, New York, NY 10003 Phone: 212-420-6460 Fax: 646-602-1091 | |
Avraham Y Henoch Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 564 W 160th St, New York, NY 10032 Phone: 212-740-6400 Fax: 212-740-4105 | |
Vincent Esposito Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10 W 86th St, Ste 1a, New York, NY 10024 Phone: 212-595-1234 Fax: 212-595-0342 | |
Jeffrey Glick Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 117 E 65th St, New York, NY 10065 Phone: 212-861-4278 | |
Columbiadoctors Ambulatory Care Network Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 630 W 168th St, Bb 2-239, New York, NY 10032 Phone: 212-305-1181 |